Version 5.4
Bos taurus Protein: BT.19972
Summary
InnateDB Protein IDBP-684818.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.19972
Protein Name solute carrier family 15 member 1
Synonyms PEPT-1; PEPT1;
Species Bos taurus
Ensembl Protein ENSBTAP00000005822
InnateDB Gene IDBG-633104 (BT.19972)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005215 transporter activity
GO:0005427 proton-dependent oligopeptide secondary active transmembrane transporter activity
GO:0015198 oligopeptide transporter activity
Biological Process
GO:0006810 transport
GO:0006857 oligopeptide transport
GO:0035672 oligopeptide transmembrane transport
Cellular Component
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR000109 Proton-dependent oligopeptide transporter family
IPR004768 Oligopeptide transporter
IPR016196 Major facilitator superfamily domain, general substrate transporter
PFAM PF00854
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q0KK89
UniProt Splice Variant
Entrez Gene 521181
UniGene Bt.19972
RefSeq NP_001092848
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AB252574 DAAA02034719 DAAA02034720
GenPept BAF30929

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca